comparemela.com

Latest Breaking News On - Biostem technologies inc - Page 19 : comparemela.com

Global Soft Tissue Allografts Market To Be Driven By The Increase In The Frequency Of Orthopedic Surgeries And Dental Implants In The Forecast Period Of 2021-2026

APOGEE SILVER LTD (AGEEF) - Cannabis Movers & Shakers: Halo Collective, Suite 420 Access, OWP, BioStem, Chicago Atlantic Advisors, Silo Wellness

Halo Collective Taps Have a Heart s CEO Ryan Kunkel Halo Collective Inc. (NEO:HALO)(OTCQX:AGEEF) has welcomed Have a Heart s CEO and founder Ryan Kunkel to serve as its vice-chairman and an independent director. Kunkel is a seasoned cannabis expert and entrepreneur with experience in operations, fundraising, and application development. As our operations continue to expand and we open our first dispensaries in Los Angeles and acquire Kush Bar dispensaries from High Tide in Alberta, Canada, it s imperative for Halo to look at the big picture and bring Ryan to our senior team, Louisa Mojela, the company s executive chairman, said Friday.

BioStem Technologies, Inc Announces Launch of National Sales Force Expansion

BioStem Technologies, Inc Announces Launch of National Sales Force Expansion
apnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from apnews.com Daily Mail and Mail on Sunday newspapers.

BioStem Technologies, Announces Filing of 2020 Quarterly Reports

BioStem Technologies, Announces Filing of 2020 Quarterly Reports Pompano Beach, Fl, Dec. 24, 2020 (GLOBE NEWSWIRE) BioStem Technologies, Inc. (OTC PINK: BSEM) (“BioStem” or the “Company”), a leading life sciences company specializing in perinatal tissue allografts for use in regenerative therapies, today announced that it has filed its quarterly reports for 2020 to become current with OTC Markets. BioStem’s Chief Executive Officer, Jason Matuszewski, commented, “The filing of our 2020 quarterly reports not only marks a key milestone for BioStem, but also reflects the level of transparency we strive to achieve for our shareholders. Current financial reporting, along with increased and timely dialogue, are a top priority. We also continue to take actions that focus on improving the lives of patients and their families, provide business resiliency, and restore the Company’s financial integrity and reputation. We feel confident we can maintain current status with our re

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.